JY
BTCY

Jeff Yass’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Jeff Yass’s Portfolio BTCY Stock Details BTCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,933
Closed -$67K – 14212
2022
Q1 		$67K Sell
4,933
-4,017
-45% -$69.7K ﹤0.01% 12157
2021
Q4 		$214K Buy
+8,950
New +$211K ﹤0.01% 11308

Other funds holding BTCY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $450M AUM 41.19% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Jeff Yass's BTCY Position: Q4 2023 in Review

Jeff Yass sold out of Biotricity, Inc. Common Stock (BTCY) in Q4 2023, closing a stake of 30,533 shares — an estimated $63.8K sold.

Jeff Yass first reported a position in BTCY in Q4 2021 and held it in 5 quarters. The position peaked at $109K in Q4 2021. 21 funds tracked by Wall St. Rank hold BTCY as of Q4 2023.

  • Jeff Yass reported no remaining Biotricity, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Jeff Yass sold 30,533 Biotricity, Inc. Common Stock shares in Q4 2023, an estimated $63.8K.
  • Jeff Yass first reported a position in Biotricity, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Jeff Yass's Biotricity, Inc. Common Stock position peaked at $109K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.